Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Consensus Rating of "Hold" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 1,800,000 shares, a growth of 22.4% from the November 30th total of 1,470,000 shares. Approximately 9.2% of the company’s stock are short sold. […]
Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded at StockNews.com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) had its price objective lowered by HC Wainwright from $30.00 to $28.00 in a report issued on Tuesday, Benzinga reports. The brokerage currently has a buy rating on the biotechnology company’s stock. A number of other analysts have also weighed in on ENTA. JPMorgan Chase & Co. lowered shares […]
Enanta Pharmaceuticals (NASDAQ:ENTA) Issues Quarterly Earnings Results, Beats Estimates By $0.78 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.